Cargando…
Gene Expression Profiling in Early Breast Cancer—Patient Stratification Based on Molecular and Tumor Microenvironment Features
Patients with early-stage hormone receptor-positive, human epidermal growth factor receptor 2-negative (HER2−) breast cancer (BC) are typically treated with surgery, followed by adjuvant systemic endocrine therapy with or without adjuvant chemotherapy and radiation therapy. Current guidelines regard...
Autores principales: | Munkácsy, Gyöngyi, Santarpia, Libero, Győrffy, Balázs |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869155/ https://www.ncbi.nlm.nih.gov/pubmed/35203458 http://dx.doi.org/10.3390/biomedicines10020248 |
Ejemplares similares
-
Therapeutic Potential of Tumor Metabolic Reprogramming in Triple-Negative Breast Cancer
por: Munkácsy, Gyöngyi, et al.
Publicado: (2023) -
Pancancer survival analysis of cancer hallmark genes
por: Nagy, Ádám, et al.
Publicado: (2021) -
Independent validation of induced overexpression efficiency across 242 experiments shows a success rate of 39%
por: Munkácsy, Gyöngyi, et al.
Publicado: (2019) -
Comparison of scientometric achievements at PhD and scientific output ten years later for 4,790 academic researchers
por: Munkácsy, Gyöngyi, et al.
Publicado: (2022) -
An integrative bioinformatics approach reveals coding and non-coding gene variants associated with gene expression profiles and outcome in breast cancer molecular subtypes
por: Győrffy, Balázs, et al.
Publicado: (2018)